Do genetic variants related to nondihydropyridine CCBs inform on the risk of diverticulosis?
Genetic variants related to nondihydropyridine CCBs suggest a potential effect on diverticulosis risk, warranting further investigation.
Genetic variants can be used to explore the efficacy and side effects of antihypertensive medications. The identified potential effect of nondihydropyridine CCBs on diverticulosis risk could have clinical implications and warrants further investigation.
Gill et al. (Tue,) studied this question.